Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of...